This topic contains a solution. Click here to go to the answer

Author Question: Sally writes a behavioral contract with the school counselor in which she commits to studying 2 ... (Read 267 times)

Sportsfan2111

  • Hero Member
  • *****
  • Posts: 585
Sally writes a behavioral contract with the school counselor in which she commits to studying 2 hours per evening. If she does (as verified by her mother), she avoids the loss of 10 that she deposited with the counselor. This is an example of a:
 
  a. one party contract
 b. quid pro quo contract
  c. parallel contract
 d. two party contract

Question 2

Forward chaining and backward chaining both involve:
 
  a. teaching one component of the behavioral chain at a time
  b. the use of prompting and fading
 c. the use of reinforcers after each response in the chain
 d. all of these



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

irishcancer18

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

a

Answer to Question 2

d





 

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library